ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Precision Neuroscience Named to Fast Company’s World Changing Ideas and Inc.’s Best Workplaces Lists

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, has been named to two prestigious lists: Fast Company’s World Changing Ideas and Inc.’s 2025 Best Workplaces.

Fast Company recognized Precision for its Layer 7 Cortical Interface, a high-resolution electrode array that forms the core of its BCI system. The device is designed to help people with paralysis caused by conditions such as stroke, spinal cord injury, and ALS. Recently cleared by the U.S. Food and Drug Administration (FDA), the Layer 7 Cortical Interface can record, monitor, and stimulate electrical activity on the brain’s surface. It is designed to be implanted using a minimally invasive technique and to avoid damage to brain tissue, instead conforming gently to the surface of the brain. When used as part of Precision’s full BCI system, it will enable users to control digital devices—such as computers and smartphones—using only their thoughts.

The Fast Company list honors companies developing bold, scalable solutions to major global challenges. A panel of editors and reporters evaluated more than 1,500 entries based on impact and potential to improve society. “The World Changing Ideas Awards have always been about showcasing the art of the possible,” Fast Company’s editor-in-chief, Brendan Vaughan, said. “We’re proud to recognize the organizations and leaders that are making meaningful progress on the biggest issues of our time.”

Inc.’s 2025 Best Workplaces list highlights companies with outstanding workplace culture. The selection process included an audit of benefits and an employee survey by Quantum Workplace, evaluating management, perks, professional growth, and overall satisfaction.

Michael Mager, Precision’s co-founder and CEO, said, "We’re proud to be recognized both for the impact of our technology and the culture we’re building. In the past year, we’ve advanced our clinical work—testing our device in more than 40 patients to date—received our first FDA clearance, and grown our team, adding extraordinary talent across science, engineering, and operations. Our mission is ambitious—and it's made possible by the people here who are determined to bring this life-changing technology to those who need it."

ABOUT PRECISION
Precision Neuroscience is working to provide breakthrough treatments for the millions of people worldwide suffering from neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.

Contact:
media@precisionneuro.io

ABOUT FAST COMPANY
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.

ABOUT INC.
Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.